IRVINE, Calif., September 25, 2020 — Ascendiant Capital Markets, LLC (“Ascendiant”) announced today the closing of a $6,800,000 At-the-Market Offering for ENDRA Life Sciences, Inc. (NasdaqGS: NDRA) of Ann Arbor, Michigan. For a copy of the announcement, please click here.